ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
19.95
+0.11 (0.55%)
Oct 6, 2025, 4:00 PM EDT - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $809.35 million as of October 6, 2025. Its market cap has increased by 2.15% in one year.
Market Cap
809.35M
Enterprise Value
573.76M
1-Year Change
2.15%
Ranking
Category
Stock Price
$19.95
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $809.35M, an increase of 40.70%. That is a compound annual growth rate of 22.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 804.89M | -10.34% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |